MJ, A. A., GSQ, T., MTY, L., Z, A., & JS, B. (2025). SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence. Journal of diabetes research, 2025, 5888495. https://doi.org/10.1155/jdr/5888495
Chicago Style (17th ed.) CitationMJ, Alfonso Arvez, Tan GSQ, Leung MTY, Ademi Z, and Bell JS. "SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence." Journal of Diabetes Research 2025 (2025): 5888495. https://doi.org/10.1155/jdr/5888495.
MLA (9th ed.) CitationMJ, Alfonso Arvez, et al. "SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence." Journal of Diabetes Research, vol. 2025, 2025, p. 5888495, https://doi.org/10.1155/jdr/5888495.